VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $366,282,854 | -19.0% | 13,611,403 | -9.4% | 0.13% | -17.6% |
Q2 2023 | $452,304,891 | -16.7% | 15,021,750 | -10.5% | 0.15% | -23.1% |
Q1 2023 | $542,666,463 | -5.9% | 16,774,852 | -16.7% | 0.20% | -7.4% |
Q4 2022 | $576,935,028 | +39.4% | 20,130,322 | +17.3% | 0.22% | +18.8% |
Q3 2022 | $413,977,000 | -31.4% | 17,163,222 | -22.2% | 0.18% | -27.0% |
Q2 2022 | $603,858,000 | -37.4% | 22,054,684 | -12.3% | 0.25% | -23.0% |
Q1 2022 | $964,914,000 | +14.6% | 25,160,724 | -4.3% | 0.32% | +33.6% |
Q4 2021 | $841,802,000 | +7.5% | 26,281,715 | -1.1% | 0.24% | -2.0% |
Q3 2021 | $782,764,000 | +24.7% | 26,561,393 | +43.8% | 0.25% | +21.8% |
Q2 2021 | $627,589,000 | -5.1% | 18,469,377 | -9.3% | 0.20% | -8.2% |
Q1 2021 | $661,662,000 | -26.8% | 20,358,767 | -18.9% | 0.22% | -27.9% |
Q4 2020 | $903,810,000 | +9.2% | 25,091,899 | +18.7% | 0.30% | -1.9% |
Q3 2020 | $827,509,000 | -5.4% | 21,131,489 | -11.4% | 0.31% | -15.7% |
Q2 2020 | $874,557,000 | +65.1% | 23,842,913 | +3.7% | 0.37% | +47.6% |
Q1 2020 | $529,646,000 | -58.2% | 22,988,098 | -46.9% | 0.25% | -43.4% |
Q4 2019 | $1,268,411,000 | +34.1% | 43,320,090 | +22.4% | 0.44% | +21.1% |
Q3 2019 | $945,571,000 | -14.2% | 35,401,366 | -17.8% | 0.36% | -14.1% |
Q2 2019 | $1,101,460,000 | +66.4% | 43,093,126 | +46.0% | 0.42% | +55.7% |
Q1 2019 | $661,966,000 | -23.8% | 29,525,676 | -28.3% | 0.27% | -30.7% |
Q4 2018 | $868,750,000 | +165.5% | 41,192,468 | +133.1% | 0.39% | +203.1% |
Q3 2018 | $327,240,000 | -41.3% | 17,669,517 | -29.3% | 0.13% | -46.1% |
Q2 2018 | $557,775,000 | -9.8% | 25,001,066 | -11.2% | 0.24% | -9.7% |
Q1 2018 | $618,606,000 | +19.9% | 28,144,087 | +26.8% | 0.27% | +25.4% |
Q4 2017 | $515,951,000 | +93.6% | 22,201,007 | +91.2% | 0.21% | +73.2% |
Q3 2017 | $266,552,000 | -22.3% | 11,609,404 | -25.3% | 0.12% | -30.9% |
Q2 2017 | $343,009,000 | -39.3% | 15,534,805 | -37.3% | 0.18% | -42.4% |
Q1 2017 | $565,554,000 | +40.6% | 24,794,081 | +29.0% | 0.31% | +39.2% |
Q4 2016 | $402,103,000 | +71.2% | 19,220,985 | +116.3% | 0.22% | +58.6% |
Q3 2016 | $234,874,000 | -52.3% | 8,886,688 | -50.0% | 0.14% | -54.8% |
Q2 2016 | $492,776,000 | – | 17,783,342 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |